E11
Conditions
Interventions
Group 1: In the control group, at the beginning of the enrollment, a status-quo home-visit (t0) is performed to identify predefined adverse effects, drug-related problems, and adherence. 4-6 weeks aft
Sponsors
Universität Leipzig
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients are enrolled if they had a diagnosis of type 2 diabetes mellitus (ICD-10 E11) and are prescribed at least one (or more) antidiabetic medication (e.g., insulin, peroral and injectable antidiabetic agents) prior to study enrollment. In addition, patients have to be of legal age (=18 years), live at home, take responsibility for the administration of their medicines, and having given their written informed consent to participate in advance.
Exclusion criteria
Exclusion criteria: Patients are not enrolled if they have not a diagnosis of type 2 diabetes mellitus (ICD-10 E11) and are not prescribed at least one (or more) antidiabetic medication (e.g., insulin, peroral and injectable antidiabetic agents) prior to study enrollment. Patients not being of legal age (=18 years), not living at home, not taking responsibility for the administration of their medicines, and not having given their written informed consent to participate in advance are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Gastrointestinal adverse effects (primary outcome) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Hypoglycemic adverse effects (secondary outcome) - Dermatological adverse effects (secondary outcome) - Drug-related problems (secondary outcome) - Adherence (secondary outcome) | — |
Countries
Germany
Contacts
Public ContactThilo Bertsche
Universität Leipzig
Outcome results
None listed